Nine publications from the past two weeks:

• Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions | link
• Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort | link
• Resource allocation in genetic and genomic medicine | link (the rest of this Special Issue is available here)
• Correspondence on “Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions” by Lavelle et al | link
• Response to Grosse and Gudgeon | link
• Economic Aspects in Precision Medicine and Pharmacogenomics | link
• Economic evaluation of using polygenic risk score to guide risk screening and interventions for the prevention of type 2 diabetes in individuals with high overall baseline risk | link
• Epistemic justice, African values and feedback of findings in African genomics research | link
• Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.